Alto Neuroscience Ownership | Who Owns Alto Neuroscience?
Alto Neuroscience Ownership Summary
Alto Neuroscience is owned by 83.57% institutional investors, 7.51% insiders, and 8.92% retail investors. Nelson, van denburg & campbell wealth management group is the largest institutional shareholder, holding 0% of ANRO shares.
ANRO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Alto Neuroscience | 83.57% | 7.51% | 8.92% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nelson, van denburg & campbell wealth management group | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Nelson, van denburg & campbell wealth management group | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Nelson, van denburg & campbell wealth management group | - | - | -249.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Nelson, van denburg & campbell wealth management group | - | - | -249.00 |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -249.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 81 | -5.81% | 22,530,140 | -1.78% | 83 | 1.15% | 52 | -21.21% | 13 | 44.44% |
Sep 30, 2024 | 86 | 48.28% | 22,939,574 | 23.33% | 85 | 1.79% | 66 | 69.23% | 9 | -10.00% |
Jun 30, 2024 | 58 | 11.54% | 18,600,674 | 16.67% | 69 | 1.96% | 39 | -25.00% | 10 | - |
Mar 31, 2024 | 52 | - | 15,943,412 | - | 59 | - | 52 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $38.75K |
Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $18.25K |
Jul 09, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | Buy | $133.83K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q3 | 3 | - |
ANRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools